$1.90
00.00%
Pre-Market: Sep 20, 5:57 PM EDT
15 minutes delayed
Aerovate Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aerovate Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.86 | $-0.83 | -3.61 % |
Mar 2024 | 2024-05-13 | $-0.83 | $-0.68 | -22.1 % |
Dec 2023 | 2024-03-25 | $-0.74 | $-0.71 | -4.23 % |
Sep 2023 | 2023-11-13 | $-0.71 | $-0.69 | -2.90 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Aerovate Therapeutics (AVTE) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.86, which missed the estimate of $-0.83.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.